Literature DB >> 3197705

Response properties of rapidly recurring hippocampal seizures in rats.

E W Lothman1, J B Perlin, R A Salerno.   

Abstract

Previous work has shown that closely spaced stimuli can activate short-term and long-term inhibitory processes that suppress kindling and the expression of kindled responses. The present experiments employed stimulus trains of longer duration than traditionally used in kindling work. Hippocampal seizures were triggered in rats at rates considerably faster than those reported to activate these inhibitory processes. Such rapidly recurring hippocampal seizures (RRHS) promptly led to a persistent, fully kindled state in which consistent kindled motor responses, constant duration electrographic seizures and stable afterdischarge thresholds were present. These kindled responses could be elicited every 30 min for 6-8 h/day on an alternate day schedule, but the kindled responses depended on delivery of supramaximal stimuli. Extending the number of RRHS on a given test day led to the appearance of a slowly developing but enduring suppression of kindled responses and an elevation of afterdischarge thresholds. Restricting the study period to 6 h on a given day, but using a consecutive instead of alternate day schedule, also led to a long-duration suppression of kindled responses. These results show that the short-duration inhibitory processes associated with kindled seizures can be more easily overcome than long-duration processes. The latter seem to involve an elevation of afterdischarge thresholds. The experiments also establish procedures by which detailed investigations of the effects of experimental manipulations on kindled responses can be examined.

Entities:  

Mesh:

Year:  1988        PMID: 3197705     DOI: 10.1016/0920-1211(88)90047-2

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  8 in total

1.  Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112).

Authors:  David F McComsey; Virginia L Smith-Swintosky; Michael H Parker; Douglas E Brenneman; Ewa Malatynska; H Steve White; Brian D Klein; Karen S Wilcox; Michael E Milewski; Mark Herb; Michael F A Finley; Yi Liu; Mary Lou Lubin; Ning Qin; Allen B Reitz; Bruce E Maryanoff
Journal:  J Med Chem       Date:  2013-11-11       Impact factor: 7.446

2.  Kindling produces long-lasting and selective changes in gene expression of hippocampal neurons.

Authors:  J B Perlin; C M Gerwin; D M Panchision; R S Vick; E R Jakoi; R J DeLorenzo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

3.  Synaptic degeneration and remodelling after fast kindling of the olfactory bulb.

Authors:  D P Woldbye; T G Bolwig; J Kragh; O S Jørgensen
Journal:  Neurochem Res       Date:  1996-05       Impact factor: 3.996

4.  A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus.

Authors:  Weiwei Yen; John Williamson; Edward H Bertram; Jaideep Kapur
Journal:  Epilepsy Res       Date:  2004-03       Impact factor: 3.045

5.  Neuronal activity up-regulates astroglial gene expression.

Authors:  O Steward; E R Torre; R Tomasulo; E Lothman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

6.  A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation.

Authors:  Brandon S Martin; Jaideep Kapur
Journal:  Epilepsia       Date:  2007-10-15       Impact factor: 5.864

7.  Assessment of the Optimal Stimulus Pattern to Achieve Rapid Dorsal Hippocampal Kindling in Rats.

Authors:  Fatemeh Etemadi; Mohammad Sayyah; Hamid Gholami Pourbadie; Vahab Babapour
Journal:  Basic Clin Neurosci       Date:  2015-04

8.  Flupirtine and diazepam combination terminates established status epilepticus: results in three rodent models.

Authors:  Terry Zhang; Marko S Todorovic; John Williamson; Jaideep Kapur
Journal:  Ann Clin Transl Neurol       Date:  2017-11-07       Impact factor: 4.511

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.